Dottikon ES Holding AG (DESNF)
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | -- |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | -- |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | -- |
| Price to Book Value | -- |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | -- |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | -- |
Profile
| Dottikon ES Holding AG engages in the development and manufacture of chemicals, intermediates, and pharmaceutical ingredients. Its products and services include exclusive synthesis, project management, active pharmaceutical ingredients, performance chemicals, containment, quality management, recycling and waste treatment, catalog products, and dottisol. The company was founded in 1913 and is headquartered in Dottikon, Switzerland. |
| URL | http://www.dottikon.com |
| Investor Relations URL | N/A |
| HQ State/Province | Aargau (Argovia) |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Equity Style | N/A |
| Next Earnings Release | Nov. 27, 2026 |
| Last Earnings Release | May. 29, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| Dottikon ES Holding AG engages in the development and manufacture of chemicals, intermediates, and pharmaceutical ingredients. Its products and services include exclusive synthesis, project management, active pharmaceutical ingredients, performance chemicals, containment, quality management, recycling and waste treatment, catalog products, and dottisol. The company was founded in 1913 and is headquartered in Dottikon, Switzerland. |
| URL | http://www.dottikon.com |
| Investor Relations URL | N/A |
| HQ State/Province | Aargau (Argovia) |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Equity Style | N/A |
| Next Earnings Release | Nov. 27, 2026 |
| Last Earnings Release | May. 29, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |